RxDoctor Payments Data

Megan Vonwerssowetz, NP

Family · Chattanooga, TNNPI 1700241783

Payments from drug & device makers

$4,984in general payments, 2019–2025

Across 282 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Lilly USA, LLC$531
  • AbbVie$352
  • AstraZeneca$309
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$295
  • Pfizer$293
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$4,984100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,984 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$13,108
Medicare patients
46
Services billed
274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$12,550
Bydureon BciseExenatide Microspheres12$10,426
Albuterol Sulfate HfaAlbuterol Sulfate42$1,190
Atorvastatin Calcium60$792
Levothyroxine Sodium80$507
Rosuvastatin Calcium28$446
Omeprazole33$440
Losartan Potassium31$401
Sertraline Hcl26$310
Lisinopril60$257
Amlodipine Besylate51$203
Fluticasone Propionate13$198
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$186
Trazodone Hcl13$162
Metformin Hcl21$152

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$133$12,55020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →